Distribution of diagnosis and recruitment of cases
| . | Frequency (%) . |
|---|---|
| Pathological diagnosis of epithelial ovarian cancer | |
| Serous cystadnocarcinoma | 106 (41.7) |
| Mucinous cystadnocarcinoma | 35 (13.8) |
| Endometrioid cystadnocarcinoma | 21 (8.3) |
| Mixed epithelial cystadnocarcinoma | 7 (2.8) |
| Undifferentiated carcinoma | 36 (14.2) |
| Borderline malignancy | 40 (15.7) |
| Clear cell carcinoma | 5 (2.0) |
| Transitional cell carcinoma | 2 (0.8) |
| Malignant Brenner’s tumor | 2 (0.8) |
| Months between diagnosis and interview | |
| 1–12 | 191 (75.2) |
| 13–24 | 34 (13.4) |
| 25–36 | 29 (11.4) |
| Type of interview | |
| In person | 241 (95) |
| Next of kin | 13 (5) |
| Place of interview | |
| Hospital | 226 (89) |
| Home | 25 (10) |
| Work place | 3 (1) |
| . | Frequency (%) . |
|---|---|
| Pathological diagnosis of epithelial ovarian cancer | |
| Serous cystadnocarcinoma | 106 (41.7) |
| Mucinous cystadnocarcinoma | 35 (13.8) |
| Endometrioid cystadnocarcinoma | 21 (8.3) |
| Mixed epithelial cystadnocarcinoma | 7 (2.8) |
| Undifferentiated carcinoma | 36 (14.2) |
| Borderline malignancy | 40 (15.7) |
| Clear cell carcinoma | 5 (2.0) |
| Transitional cell carcinoma | 2 (0.8) |
| Malignant Brenner’s tumor | 2 (0.8) |
| Months between diagnosis and interview | |
| 1–12 | 191 (75.2) |
| 13–24 | 34 (13.4) |
| 25–36 | 29 (11.4) |
| Type of interview | |
| In person | 241 (95) |
| Next of kin | 13 (5) |
| Place of interview | |
| Hospital | 226 (89) |
| Home | 25 (10) |
| Work place | 3 (1) |